Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's

Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered

Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM

Endpoints NewsFDA warns telehealth companies over compounded GLP-1s

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

Endpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says

Endpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipes

Endpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approval

BioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera deal

Clinical OMICsVibrating Pill Predicts Anorexia Relapse

FierceBiotechVedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies

FierceBiotechUniQure stock surges after FDA U-turn clears path to gene therapy filing